Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Psychometric Properties of a Modified KINDL-R Questionnaire for Adolescents and Adults, and Construction of a Brief Version, the KINDL-A(dult)B(rief) Questionnaire, KINDL-AB.

Neuner B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Clausnizer H, Shneyder M, Rocke A, Nowak-Göttl U.

Acta Haematol. 2018;140(1):1-9. doi: 10.1159/000490408. Epub 2018 Jul 13.

PMID:
30007981
2.

Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M.

J Mol Med (Berl). 2018 Jun 22. doi: 10.1007/s00109-018-1661-6. [Epub ahead of print]

PMID:
29934777
3.

Hemostasis in the Very Young.

Kenet G, Barg AA, Nowak-Göttl U.

Semin Thromb Hemost. 2018 Oct;44(7):617-623. doi: 10.1055/s-0038-1660852. Epub 2018 Jun 18.

PMID:
29913536
4.

Thrombophilia testing in children: What and when should be tested?

Nowak-Göttl U, van Ommen H, Kenet G.

Thromb Res. 2018 Apr;164:75-78. doi: 10.1016/j.thromres.2018.02.136. Epub 2018 Feb 21. Review.

PMID:
29518638
5.

Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H.

Transfus Med. 2017 Dec 27. doi: 10.1111/tme.12498. [Epub ahead of print]

PMID:
29280212
6.

Editorial for special pediatric hemostasis issue BCMD.

Kenet G, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:1. doi: 10.1016/j.bcmd.2017.09.010. No abstract available.

PMID:
29113682
7.

Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test.

van Ommen CH, Nowak-Göttl U.

Front Pediatr. 2017 Mar 14;5:50. doi: 10.3389/fped.2017.00050. eCollection 2017. Review.

8.

The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years.

Nowak-Göttl U, Dietrich K, Kruempel A, Geisen C, Mitchell LG.

Blood Cells Mol Dis. 2017 Sep;67:54-58. doi: 10.1016/j.bcmd.2016.12.012. Epub 2016 Dec 30.

PMID:
28284562
9.

Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.

Boeckelmann D, Hengartner H, Greinacher A, Nowak-Göttl U, Sachs UJ, Peter K, Sandrock-Lang K, Zieger B.

Blood Cells Mol Dis. 2017 Sep;67:69-74. doi: 10.1016/j.bcmd.2017.01.010. Epub 2017 Jan 22.

PMID:
28131619
10.

Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.

Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak Göttl U, Kenet G.

Blood Cells Mol Dis. 2017 Sep;67:14-17. doi: 10.1016/j.bcmd.2016.12.013. Epub 2016 Dec 29.

PMID:
28087247
11.

Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D.

Blood Cells Mol Dis. 2017 Sep;67:2-13. doi: 10.1016/j.bcmd.2016.11.012. Epub 2016 Dec 5.

PMID:
28017497
12.

Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism.

Rühle F, Witten A, Barysenka A, Huge A, Arning A, Heller C, Krümpel A, Mesters R, Franke A, Lieb W, Riemenschneider M, Hiersche M, Limperger V, Nowak-Göttl U, Stoll M.

Blood. 2017 Feb 9;129(6):783-790. doi: 10.1182/blood-2016-07-728840. Epub 2016 Dec 23.

13.

Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?

Kenet G, Limperger V, Shneyder M, Nowak-Göttl U.

Blood Cells Mol Dis. 2017 Sep;67:18-22. doi: 10.1016/j.bcmd.2016.12.003. Epub 2016 Dec 14. Review.

PMID:
28010922
14.

Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders.

Nowak-Göttl U, Clausnizer H, Kowalski D, Limperger V, Krümpel A, Shneyder M, Reinke S, Rocke A, Juhl D, Steppat D, Krause M.

Blood Cells Mol Dis. 2017 Sep;67:96-101. doi: 10.1016/j.bcmd.2016.11.010. Epub 2016 Nov 12.

PMID:
27865683
15.

Impact of high risk thrombophilia status on recurrence among children and adults with VTE: An observational multicenter cohort study.

Brüwer G, Limperger V, Kenet G, Klostermeier UC, Shneyder M, Degenhardt F, Finckh U, Heller C, Holzhauer S, Trappe R, Kentouche K, Knoefler R, Kurnik K, Krümpel A, Lauten M, Manner D, Mesters R, Junker R, Nowak-Göttl U.

Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024. Epub 2016 Nov 5.

PMID:
27838551
16.

Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.

Hartmann S, Biliouris K, Lesko LJ, Nowak-Göttl U, Trame MN.

CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111. Epub 2016 Sep 20.

17.

Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.

Krause M, Henningsen A, Torge A, Juhl D, Junker R, Kenet G, Kowalski D, Limperger V, Mesters R, Anonymous, Rocke A, Shneyder M, Clausnizer H, Schiesewitz H, Nowak-Göttl U.

Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007. Epub 2016 Sep 13. No abstract available.

PMID:
27687905
18.

Haemostasis - an indispensable, cross-sectional medical discipline.

Nowak-Göttl U, Kehrel BE.

Thromb Haemost. 2016 Sep 27;116(4):595-6. doi: 10.1160/TH16-08-0648. Epub 2016 Aug 25. No abstract available.

PMID:
27609222
19.

Rare Variants in the ADAMTS13 Von Willebrand Factor-Binding Domain Contribute to Pediatric Stroke.

Stoll M, Rühle F, Witten A, Barysenka A, Arning A, Strauss C, Nowak-Göttl U.

Circ Cardiovasc Genet. 2016 Aug;9(4):357-67. doi: 10.1161/CIRCGENETICS.115.001184. Epub 2016 Jul 13.

PMID:
27412500
20.

Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study.

Limperger V, Kenet G, Goldenberg NA, Heller C, Holzhauer S, Junker R, Klostermeier UC, Knoefler R, Kurnik K, Krümpel A, Mesters R, Stach M, Young G, Nowak-Göttl U.

Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192. Epub 2016 Jun 22.

PMID:
27329967
21.

Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers.

Neuner B, von Mackensen S, Holzhauer S, Funk S, Klamroth R, Kurnik K, Krümpel A, Halimeh S, Reinke S, Frühwald M, Nowak-Göttl U.

Biomed Res Int. 2016;2016:1579428. doi: 10.1155/2016/1579428. Epub 2016 May 15.

22.

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.

Werwitzke S, Geisen U, Nowak-Göttl U, Eichler H, Stephan B, Scholz U, Holstein K, Klamroth R, Knöbl P, Huth-Kühne A, Bomke B, Tiede A.

J Thromb Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

23.

ADAMTS genes and the risk of cerebral aneurysm.

Arning A, Jeibmann A, Köhnemann S, Brokinkel B, Ewelt C, Berger K, Wellmann J, Nowak-Göttl U, Stummer W, Stoll M, Holling M.

J Neurosurg. 2016 Aug;125(2):269-74. doi: 10.3171/2015.7.JNS154. Epub 2016 Jan 8.

PMID:
26745484
24.

Bleeding issues in neonates and infants - update 2015.

Nowak-Göttl U, Limperger V, Bauer A, Kowalski D, Kenet G.

Thromb Res. 2015 Feb;135 Suppl 1:S41-3. doi: 10.1016/S0049-3848(15)50440-4. Epub 2015 Feb 9. Review.

PMID:
25903533
25.

End-stage renal disease and thrombophilia.

Bauer A, Limperger V, Nowak-Göttl U.

Hamostaseologie. 2016 May 10;36(2):103-7. doi: 10.5482/HAMO-14-11-0063. Epub 2015 Feb 2. Review.

PMID:
25639843
26.

Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A. A patient-level meta-analysis.

Marcucci M, Mancuso ME, Santagostino E, Kenet G, Elalfy M, Holzhauer S, Bidlingmaier C, Escuriola Ettingshausen C, Iorio A, Nowak-Göttl U.

Thromb Haemost. 2015 May;113(5):958-67. doi: 10.1160/TH14-07-0621. Epub 2015 Jan 29.

PMID:
25631402
27.

Proteomic and other mass spectrometry based "omics" biomarker discovery and validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, unmet needs, and future directions.

Goldenberg NA, Everett AD, Graham D, Bernard TJ, Nowak-Göttl U.

Proteomics Clin Appl. 2014 Dec;8(11-12):828-36. doi: 10.1002/prca.201400062. Review.

PMID:
25379629
28.

Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study.

Ichord RN, Benedict SL, Chan AK, Kirkham FJ, Nowak-Göttl U; International Paediatric Stroke Study Group.

Arch Dis Child. 2015 Feb;100(2):174-9. doi: 10.1136/archdischild-2014-306382. Epub 2014 Oct 6.

PMID:
25288688
29.

Role of protein S deficiency in children with venous thromboembolism. An observational international cohort study.

Klostermeier UC, Limperger V, Kenet G, Kurnik K, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Knöfler R, Holzhauer S, Mesters R, Krümpel A, Nowak-Göttl U.

Thromb Haemost. 2015 Feb;113(2):426-33. doi: 10.1160/TH14-06-0533. Epub 2014 Oct 2.

PMID:
25272994
30.

Challenging aspects of managing hemostasis in adolescents.

Nowak-Göttl U, Kenet G.

Acta Haematol. 2014;132(3-4):326-30. doi: 10.1159/000360237. Epub 2014 Sep 10. Review.

PMID:
25228558
31.

Clinical and laboratory characteristics of children with venous thromboembolism and protein C-deficiency: an observational Israeli-German cohort study.

Limperger V, Klostermeier UC, Kenet G, Holzhauer S, Alhenc Gelas M, Finckh U, Junker R, Heller C, Zieger B, Kurnik K, Knöfler R, Mesters R, Halimeh S, Nowak-Göttl U.

Br J Haematol. 2014 Nov;167(3):385-93. doi: 10.1111/bjh.13039. Epub 2014 Jul 18.

PMID:
25039884
32.

Clinical and laboratory characteristics of paediatric and adolescent index cases with venous thromboembolism and antithrombin deficiency. An observational multicentre cohort study.

Limperger V, Franke A, Kenet G, Holzhauer S, Picard V, Junker R, Heller C, Gille C, Manner D, Kurnik K, Knoefler R, Mesters R, Halimeh S, Nowak-Göttl U.

Thromb Haemost. 2014 Sep 2;112(3):478-85. doi: 10.1160/TH14-02-0149. Epub 2014 Jun 26.

PMID:
24966143
33.

[Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].

Nowak-Göttl U, Langer F, Limperger V, Mesters R, Trappe RU.

Dtsch Med Wochenschr. 2014 Jun;139(24):1301-6. doi: 10.1055/s-0034-1370110. Epub 2014 Jun 3. Review. German.

PMID:
24892468
34.

Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database study.

Kenet G, Bidlingmaier C, Bogdanova N, Ettingshausen CE, Goldenberg N, Gutsche S, Halimeh S, Holzhauer S, Kurnik K, Limperger V, Junker R, Nowak-Göttl U.

Thromb Res. 2014 Apr;133(4):544-9. doi: 10.1016/j.thromres.2014.01.005. Epub 2014 Jan 17.

35.

Subcutaneous protein C concentrate in the management of severe protein C deficiency--experience from 12 centres.

Minford A, Behnisch W, Brons P, David M, Gomez Gomez N, Hertfelder HJ, Kruempel A, Kurnik K, Mathias M, Molines Honrubia A, Monagle P, Morgan M, Nowak-Göttl U, Olivieri M.

Br J Haematol. 2014 Feb;164(3):414-21. doi: 10.1111/bjh.12640.

PMID:
24422725
36.

Advances in understanding stroke risk in children--a geneticist's view.

Stoll M, Rühle F, Nowak-Göttl U.

Br J Haematol. 2014 Mar;164(5):636-45. doi: 10.1111/bjh.12706. Epub 2013 Dec 19. Review.

PMID:
24354735
37.

[Thromboembolisms in childhood and adolescence].

Limperger V, Nowak-Göttl U.

Kinderkrankenschwester. 2013 Oct;32(10):396-401. German. No abstract available.

PMID:
24303594
38.

Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study.

Halimeh S, Bidlingmaier C, Heller C, Gutsche S, Holzhauer S, Kenet G, Kurnik K, Manner D, Iorio A, Nowak-Göttl U.

Biomed Res Int. 2013;2013:901975. doi: 10.1155/2013/901975. Epub 2013 Oct 2.

39.

Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.

Nowak-Göttl U, Krümpel A, Russo A, Jansen M.

Haemophilia. 2013 Nov;19(6):887-92. doi: 10.1111/hae.12237. Epub 2013 Aug 6.

PMID:
23919249
40.

Testing for apolipoprotein(a) phenotype using isoelectric focusing and immunoblotting technique.

Langer C, Tambyrayah B, Nowak-Göttl U.

Methods Mol Biol. 2013;992:407-12. doi: 10.1007/978-1-62703-339-8_33.

PMID:
23546733
41.

Venous thromboembolism in neonates and children--update 2013.

Nowak-Göttl U, Janssen V, Manner D, Kenet G.

Thromb Res. 2013 Jan;131 Suppl 1:S39-41. doi: 10.1016/S0049-3848(13)70019-7.

PMID:
23452739
42.

Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study.

Lambers M, Goldenberg NA, Kenet G, Kirkham FJ, Manner D, Bernard T, Mesters RM, Junker R, Stoll M, Nowak-Göttl U.

Ann Neurol. 2013 Jan;73(1):58-64. doi: 10.1002/ana.23735. Epub 2012 Dec 7.

43.

A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke.

Arning A, Hiersche M, Witten A, Kurlemann G, Kurnik K, Manner D, Stoll M, Nowak-Göttl U.

Blood. 2012 Dec 20;120(26):5231-6. doi: 10.1182/blood-2012-07-442038. Epub 2012 Sep 18.

44.

Venous thromboembolism in neonates and children.

Kenet G, Nowak-Göttl U.

Best Pract Res Clin Haematol. 2012 Sep;25(3):333-44. doi: 10.1016/j.beha.2012.07.001. Epub 2012 Aug 15. Review.

PMID:
22959549
45.

Inherited thrombophilia in children with venous thromboembolism and the familial risk of thromboembolism: an observational study.

Holzhauer S, Goldenberg NA, Junker R, Heller C, Stoll M, Manner D, Mesters R, Krümpel A, Stach M, Nowak-Göttl U.

Blood. 2012 Aug 16;120(7):1510-5. doi: 10.1182/blood-2012-01-405514. Epub 2012 May 11.

46.

EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates.

Lebas A, Chabrier S, Fluss J, Gordon K, Kossorotoff M, Nowak-Göttl U, de Vries LS, Tardieu M; French Society for Paediatric Neurology; European Paediatric Neurology Society.

Eur J Paediatr Neurol. 2012 May;16(3):219-28. doi: 10.1016/j.ejpn.2012.02.005. Epub 2012 Mar 16.

PMID:
22425391
47.

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, Vesely SK.

Chest. 2012 Feb;141(2 Suppl):e737S-e801S. doi: 10.1378/chest.11-2308. Erratum in: Chest. 2014 Nov;146(5):1422. Chest. 2014 Dec;146(6):1694. Dosage error in article text.

48.

Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies.

Bidlingmaier C, Kenet G, Kurnik K, Mathew P, Manner D, Mitchell L, Krümpel A, Nowak-Göttl U.

Semin Thromb Hemost. 2011 Oct;37(7):814-25. doi: 10.1055/s-0031-1297173. Epub 2011 Dec 20. Review.

PMID:
22187405
49.

Testing for lipoprotein(a) concentration and apolipoprotein(a) phenotypes: method standardization and pediatric reference values.

Langer C, Tambyrayah B, Thedieck S, Nowak-Göttl U.

Semin Thromb Hemost. 2011 Oct;37(7):810-3. doi: 10.1055/s-0031-1297172. Epub 2011 Dec 20.

PMID:
22187404
50.

Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis.

Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U.

Semin Thromb Hemost. 2011 Oct;37(7):802-9. doi: 10.1055/s-0031-1297171. Epub 2011 Dec 20. Review.

PMID:
22187403

Supplemental Content

Loading ...
Support Center